- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| CELC | Celcuity Inc. (PRN) | 0.12% | 30,750,000 | $69,158,687 | 30,750,000 | New | $2.25 | 13F |
| FTH | Faeth Therapeutics, Inc. | 0.06% | 1,286,411 | $32,160,275 | 1,286,411 | New | $25 | 13F |
| CYTK | Cytokinetics, Incorporated | 0.03% | 211,267 | $17,997,836 | 211,267 | New | $85.19 | 13F |
| NTLA | Intellia Therapeutics, Inc. | 0.03% | 930,232 | $15,739,525 | 930,232 | New | $16.92 | 13F |
| AVTX | Avalo Therapeutics, Inc. | 0.02% | 550,000 | $10,164,000 | 550,000 | New | $18.48 | 13F |
| AVLN | Avalyn Pharma Inc. | 0.02% | 350,000 | $11,522,000 | 350,000 | New | $32.92 | 13F |
| PBLS | Parabilis Medicines, Inc. | 0.02% | 500,000 | $13,685,000 | 500,000 | New | $27.37 | 13F |
| TNGX | Tango Therapeutics, Inc. | 0.02% | 333,333 | $10,419,990 | 333,333 | New | $31.26 | 13F |
| IMNM | Immunome, Inc. | 0.00204% | 55,306 | $1,171,934 | 55,306 | New | $21.19 | 13F |